Clinical Evidence Supporting Ozempic Coverage UnitedHealthcare's coverage of Ozempic reflects a body of evidence across the SUSTAIN trial program
We review your medical history, lifestyle habits, metabolic concerns, and previous weight-management experiences
Available at: Li H, Toh PZ, Tan JY, Zin MT, Lee CY, Li B, Leolukman M, Bao H, Kang L
Side effects and safety considerations The side effect profile of the tirzepatide levocarnitine blend is primarily driven by the tirzepatide component
Adequate protein (160200g for a 200-pound person) preserves lean tissue, maintains metabolic rate, and reinforces semaglutide's satiety effect
There are two drugs in this category that have been approved the Food and Drug Administration (FDA): lubiprostone (Amitiza) and linaclotide (Linzess) (Thomas 2015)